Gene defects in dogs and people cause a progressive, inherited blindness called Retinitis Pigmentosa (XLRP). Gene therapy treatment developed at the University of Pennsylvania was able to treat this disease in dogs.
“While the exact disease mechanism of the RPGR form of XLRP is still unknown, the researchers were able to successfully treat dogs with two different RPGR mutations. The mutations disrupt photoreceptors in different ways, but both ultimately cause them to become useless for vision. While this form of blindness is rare in dogs, it is common in humans. Patients with XLRP usually begin to lose night vision as children and become almost totally blind by middle age. ” Continue reading Progressive blindness (XLRP) treatment
Penn Veterinary Researchers Say Gene Therapy Sets Stage For New Treatments For Inherited Blindness
01 May 2010
Veterinary vision scientists at the University of Pennsylvania have safely and successfully used a viral vector in targeting a class of photoreceptors of the retina called rods, a critical first step in developing gene therapies for inherited blindness caused by rod degeneration. Continue reading Gene Therapy Sets Stage For New Treatments For Inherited Blindness
Histostem Participates In Successful Stem Cell Treatment For Acute Spinal Cord Injury In Dogs
09 Feb 2010
Stem Cell Therapy International, Inc. (OTCBB: SCII) announced that Histostem Ltd. of South Korea (“Histostem”) has participated in a study resulting in the successful treatment of spinal cord injury in dogs through the use of Multipotent Stem Cells (MSCs) derived from Human Umbilical Cord Blood (HUCB). Continue reading Stem cell treatment for spinal cord injury